Clinical Trial: 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind, Placebo-masked, Parallel-group Pilot Trial to Compare the Efficacy, Tolerability, and Safety of Tolvaptan Modified-release and Imm

Brief Summary: The purpose of this study is to compare the short-term effects of two tolvaptan formulations in patients with ADPKD.